Skip to main content
. 2020 Jul 15;202(2):230–240. doi: 10.1164/rccm.201910-2083OC

Table 1.

Clinical Characteristics of 321 Critically Ill Patients Grouped by Median Alternative Complement Pathway Function

  Total (N = 321) AH50 < Median (n = 160) AH50 ≥ Median (n = 161) P Value
Age, yr, median (IQR) 57 (45–67) 56 (45–67) 58 (45–67) 0.56
Sex, F, n (%) 142 (44.2) 69 (43.1) 73 (45.3) 0.69
Race, n (%)
0.41
 White 297 (92.5) 150 (93.8) 147 (91.3)
 Black 24 (7.5) 10 (6.3) 14 (8.7)
Admission source OSH, n (%) 205 (63.9) 107 (66.9) 98 (60.9) 0.26
ARDS, n (%) 107 (33.3) 53 (33.1) 54 (33.5) 0.94
Suspected sepsis, n (%) 202 (62.9) 99 (61.9) 103 (64.0) 0.70
Modified SOFA*, median (IQR) 7 (5–9) 8 (6–10) 6 (4–8) <0.001
Chronic liver disease, n (%) 33 (10.3) 28 (17.5) 5 (3.1) <0.001
Immune suppression, n (%) 59 (18.4) 29 (18.1) 30 (18.6) 0.91
Active neoplasm, n (%) 19 (5.9) 5 (3.1) 14 (8.7) 0.034
ICU mortality, n (%) 84 (26.2) 50 (31.3) 34 (21.2) 0.050
30-d mortality, n (%) 93 (29.0) 57 (35.6) 36 (22.4) 0.023

Definition of abbreviations: AH50 = alternative complement pathway function; ARDS = acute respiratory distress syndrome; IQR = interquartile range; OSH = outside hospital; SOFA = sequential organ failure assessment score.

Odds ratio for AH50 ≥ median is 0.58 (95% confidence interval, 0.34–1.00; P = 0.050) for ICU mortality and 0.53 (95% confidence interval, 0.31–0.91; P = 0.023) for 30-day mortality. Odds ratios are adjusted for AH50 batch effect, presence of active neoplasm, sex, SOFA, and patient age.

*

Modified SOFA score calculated with neurologic score equal to 0; therefore, maximum score is 20.